Abstract-We demonstrated previously that the blood pressure of patients with IgA nephropathy becomes salt sensitive as renal damage progresses. We also showed that increased urinary angiotensinogen levels in such patients closely correlate with augmented renal tissue angiotensinogen gene expression and angiotensin II levels. Here, we investigated the relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy. Forty-one patients with IgA nephropathy consumed an ordinary salt diet (12 g/d of NaCl) for 1 week and a low-salt diet (5 g/d of NaCl) for 1 week in random order. The salt-sensitivity index was calculated as the reciprocal of the slope of the pressure-natriuresis curve drawn by linking 2 data points obtained during consumption of each diet. The urinary angiotensinogen:creatinine ratio was significantly higher in patients who consumed the ordinary salt diet compared with the low-salt diet (17.5 g/g [range: 7.3 to 35.6 g/g] versus 7.9 g/g [range: 3.1 to 14.2 g/g] of creatinine, respectively; PϽ0.001). The sodium sensitivity index in our patients positively correlated with the glomerulosclerosis score (rϭ0.43; Pϭ0.008) and changes in logarithmic urinary angiotensinogen:creatinine ratio (rϭ0.37; Pϭ0.017) but not with changes in urinary protein excretion (rϭ0.18; Pϭ0.49). In contrast, changes in sodium intake did not alter the urinary angiotensinogen:creatinine ratio in patients with Ménière disease and normal renal function (nϭ9). These data suggest that the inappropriate augmentation of intrarenal angiotensinogen induced by salt and associated renal damage contribute to the development of salt-sensitive hypertension in patients with IgA nephropathy. (Hypertension. 2011; 58:00-00.) • Online Data Supplement Key Words: angiotensinogen Ⅲ salt Ⅲ hypertension Ⅲ glomerulonephritis Ⅲ IgA nephropathy Ⅲ renin-angiotensin system S alt-sensitive hypertension is often associated with renal damage in patients with chronic kidney disease (CKD). 1 Salt-sensitive blood pressure is a risk factor for cardiovascular and renal damage and mortality. 2, 3 We showed previously that blood pressure becomes salt sensitive as renal damage progresses in patients with IgA nephropathy and normal blood pressure. 4 Although the precise mechanisms for the pathogenesis of salt sensitivity of blood pressure in patients with CKD remain unclear, accumulating evidence suggests that the intrarenal renin-angiotensin system (RAS) contributes to its initiation and progression. 1 Focus on the role of the RAS in the pathophysiology of hypertension and renal damage has shifted recently to the role of the local RAS in the kidneys. 5 Inappropriate increases in levels of angiotensin II (Ang II) in the kidneys lead to enhanced tubular sodium reabsorption and renal tissue damage, both of which might contribute to the development of salt-sensitive hypertension. 5, 6 That high-salt intake decreases both plasma and kidney Ang II levels by significantly reducing renin release from juxtaglomerular cells under physiological conditions is generally accepted. 5 A high-salt intake similarly and significantly decreases both plasma renin activity and Ang II levels in salt-sensitive hypertensive Dahl rats, a model of human salt-sensitive hypertension. 7 However, intrarenal Ang II levels increase in these rats during the development of hypertension and renal damage. 7-10 Preclinical studies have also shown that increases in intrarenal Ang II levels are associated with inappropriate augmentation of intrarenal angiotensinogen levels. 11,12 Nevertheless, no evidence yet supports the notion that the intrarenal RAS is
S alt-sensitive hypertension is often associated with renal damage in patients with chronic kidney disease (CKD). 1 Salt-sensitive blood pressure is a risk factor for cardiovascular and renal damage and mortality. 2, 3 We showed previously that blood pressure becomes salt sensitive as renal damage progresses in patients with IgA nephropathy and normal blood pressure. 4 Although the precise mechanisms for the pathogenesis of salt sensitivity of blood pressure in patients with CKD remain unclear, accumulating evidence suggests that the intrarenal renin-angiotensin system (RAS) contributes to its initiation and progression. 1 Focus on the role of the RAS in the pathophysiology of hypertension and renal damage has shifted recently to the role of the local RAS in the kidneys. 5 Inappropriate increases in levels of angiotensin II (Ang II) in the kidneys lead to enhanced tubular sodium reabsorption and renal tissue damage, both of which might contribute to the development of salt-sensitive hypertension. 5, 6 That high-salt intake decreases both plasma and kidney Ang II levels by significantly reducing renin release from juxtaglomerular cells under physiological conditions is generally accepted. 5 A high-salt intake similarly and significantly decreases both plasma renin activity and Ang II levels in salt-sensitive hypertensive Dahl rats, a model of human salt-sensitive hypertension. 7 However, intrarenal Ang II levels increase in these rats during the development of hypertension and renal damage. [7] [8] [9] [10] Preclinical studies have also shown that increases in intrarenal Ang II levels are associated with inappropriate augmentation of intrarenal angiotensinogen levels. 11, 12 Nevertheless, no evidence yet supports the notion that the intrarenal RAS is actually activated in salt-dependent hypertensive patients with renal disease. In this regard, our preclinical studies demonstrated that intrarenal angiotensinogen is a key RAS component in regulating local Ang II levels in the kidneys. 5 We also recently developed an ELISA system with which to directly measure human angiotensinogen 13, 14 and showed that increases in urinary angiotensinogen levels correlate with increased angiotensinogen expression and Ang II levels in renal tissues of patients with IgA nephropathy, suggesting that urinary angiotensinogen provides a specific index of intrarenal RAS in such patients. 15 Here, we test the hypothesis that the development of salt-sensitive hypertension is associated with increased intrarenal RAS activity in patients with IgA nephropathy by measuring their urinary angiotensinogen excretion rates after consuming diets containing different amounts of salt.
Methods

Patients With IgA Nephropathy
This retrospective exploratory study proceeded in compliance with our protocol and the principles of the Declaration of Helsinki. The ethics committee of Osaka City General Hospital reviewed and approved the protocol, patient information, and informed consent forms. Outpatients diagnosed with renal disease at Osaka City General Hospital between 1998 and 2002 (nϭ554) provided written informed consent to undergo a renal biopsy. During this period, 150 patients were diagnosed with IgA nephropathy. However, we excluded patients with other renal diseases and those taking any medication. The study was finally composed of 41 patients, including 35 who we had studied previously. 16 Table 1 shows the baseline characteristics of the patients.
Study Protocols for Patients With IgA Nephropathy
The patients were hospitalized and consumed standard hospital meals containing Ϸ10 g of NaCl per day for 1 week. They then consumed either a low-salt diet (Ϸ5 g/d of NaCl per day) or an ordinary salt diet (Ϸ12 g/d of NaCl) for 1 week in random order, with no washout period between regimens. The 2 diets contained the same amount of protein (1.2 g/kg of body weight per day) and the same number of calories (35 kcal/kg per day). On the last 3 days of the diets, sodium, protein, and angiotensinogen were assayed in portions of 24-hour urine samples that were obtained daily, frozen, and stored at Ϫ80°C. The means of these values were analyzed in the present study. On the last day of each diet, blood pressure during 24 hours was recorded hourly using an automatic oscillometric monitor (Ambulatory Blood Monitoring System, A&D Co, Tokyo, Japan). The mean arterial pressure (MAP) was calculated by adding one third of the pulse pressure to the diastolic pressure, and the results are expressed as means of these 24 values on each final day. Renal plasma flow and creatinine clearance were calculated on the same day using a standard method with para-aminohippurate and endogenous creatinine as markers. Renal clearance was standardized for a body surface area of 1.73 m 2 . On the last day of each diet, blood samples were obtained from supine patients at 8:00 AM to measure levels of electrolytes, plasma renin activity, and serum aldosterone.
Calculation of Salt-Sensitivity Index
Pressure-natriuretic curves were generated by plotting urinary sodium excretion on the ordinate as a function of the MAP on the abscissa. Assuming a linear relationship between these variables, a curve was drawn for each patient by linking the data points obtained when the sodium balance was in a steady state during each diet. The salt-sensitivity index (SSI) is equal to the reciprocal of the slope ( Figure S1 , available in the online Data Supplement; please see http://hyper.ahajournals.org). 4 
Histological Analyses
Sections of biopsy specimens containing Ն10 glomeruli from each patient were stained with periodic acid-Schiff reagent and independently evaluated by 2 investigators who were unaware of the SSI of each patient. The severity of glomerulosclerosis and of tubulointerstitial damage was semiquantified using the described scoring method. 4 Severity was graded from 0 to 4 to express the ratio (percentage) of affected glomeruli in biopsy specimens. Damage scores were then calculated by multiplying the grade of individual glomeruli by the ratio (percentage) of glomeruli with the same degree of damage. The severity of glomerulosclerosis for each tissue specimen was determined by adding these damage scores. The severity of tubulointerstitial damage in each specimen was scored as the ratio (percentage) of tubulointerstitial fibrosis, tubular atrophy, and interstitial infiltrates in the cortex.
Urinary Sampling From Patients With Ménière Disease
A low-salt diet has become a popular therapy recently for Ménière disease. 17, 18 Because Ménière disease is an inner ear disease that is not systemic, urinary samples were collected as controls from outpatients with Ménière disease and normal renal function. Between December 2007 and December 2008, we recruited 16 patients who were diagnosed at Kagawa University Medical School with Ménière disease based on the clinical course and diagnostic categories according to the 1995 guidelines from the American Academy of Otolaryngology-Head and Neck Surgery Committee of Hearing and Equilibrium. 19 We excluded patients who were pregnant, hypertensive (systolic blood pressure/diastolic blood pressure Ͼ140/ 90 mm Hg), diabetic, or who had kidney disease, hepatic diseases, infections, or malignancies. Finally, a dietitian provided nutritional guidance to 9 enrolled patients with Ménière disease to consume a low-salt diet (6 g/d of NaCl per day). Twenty-four-hour urine was collected and assayed for sodium, protein, and angiotensinogen before and 4 weeks after consuming the low-salt diet. Blood pressure was measured between 9:00 and 10:00 AM after 30 minutes of bed rest. This study proceeded in compliance with our protocol and the principles of the Declaration of Helsinki. The local institutional review board at Kagawa University Medical School reviewed and approved the protocol, the patient information, and informed consent forms.
Other Measurements
Urinary angiotensinogen levels were measured using a sandwich ELISA as described 13, 14 and urinary angiotensinogen:creatinine ratios were calculated. Serum urea nitrogen, serum and urinary creatinine, serum and urinary protein, and urinary sodium concen- Values are meanϮSD or median (25th and 75th percentiles).
trations were determined in the clinical laboratory at Osaka City General Hospital. Plasma renin activity was measured using an angiotensin I radioimmunoassay. Serum aldosterone was also measured using a radioimmunoassay.
Statistical Analysis
Values are expressed as meanϮSD, except for scores for tubulointerstitial damage, as well as values for urinary excretion of protein, urinary angiotensinogen, plasma renin activity, and SSI, which are expressed as medians (25th and 75th percentiles), because these values were not normally distributed. Significant differences among creatinine clearance, renal plasma flow, filtration fraction, and serum aldosterone in the 2 diets were evaluated using Student t test for paired samples. Significant differences among urinary excretion of protein, urinary angiotensinogen:creatinine ratio, and plasma renin activity in the 2 diets were evaluated using the Wilcoxon test. Correlations among SSI, glomerulosclerosis score, and changes in urinary excretion of protein and in logarithmic transformed urinary angiotensinogen were evaluated using a Pearson correlation. Scores for tubulointerstitial damage and other parameters were evaluated using a Spearman correlation. These parameters were assessed by multiple linear regression analysis. Data were statistically analyzed using JMP version 8 (SAS Institute Inc, Cary, NC). PϽ0.05 was considered statistically significant.
Results
Systemic and Renal Function in Patients With
IgA Nephropathy Table 2 shows urinary excretion rates of sodium and protein, MAP renal function, plasma renin activity, and serum aldosterone levels in hospitalized patients with IgA nephropathy. The MAP and the urinary excretion rate of sodium were significantly higher among patients who consumed an ordinary salt diet compared with a low-salt diet. Urinary excretion rates of protein, creatinine clearance, and effective renal plasma flow were also significantly higher among patients who consumed the ordinary salt diet. The filtration fraction did not significantly differ between the 2 diets. Plasma renin activity and serum aldosterone levels were significantly lower among patients who consumed the ordinary salt diet. The SSI in all of the patients with IgA nephropathy was 0.040 (range: 0.013 to 0.092).
Urinary Angiotensinogen and Correlation in Patients With IgA Nephropathy
The urinary angiotensinogen:creatinine ratio was significantly higher among patients with IgA nephropathy on the ordinary salt diet compared with the low-salt diet (17.5 g/g [range: 7.3 to 35.6 g/g] versus 7.9 g/g [range: 3.1 to 14.2 g/g] of creatinine, respectively; PϽ0.001; Figure 1 ). The SSI significantly correlated with scores for glomerulosclerosis or tubulointerstitial damage (Figure 2A and 2B). The SSI also significantly correlated with changes in the logarithmic urinary angiotensinogen:creatinine ratio ( Figure 3A) but not with changes in the urinary excretion rate of protein ( Figure  3B ). Multiple regression analysis of these 4 explanatory variables showed that SSI correlated with changes in the logarithmic urinary angiotensinogen:creatinine ratio but not with glomerulosclerosis scores, scores for tubulointerstitial damage, or changes in urinary protein excretion (Table 3) . Using 1 of the 2 histological parameters and the remaining 2 variables, multiple regression analysis was re-evaluated, whereas the 2 histological damage scores correlated with each other. Multiple regression analysis of 3 explanatory variables showed that SSI correlated with glomerulosclerosis scores and changes in the logarithmic urinary angiotensinogen:creatinine ratio but not with scores for tubulointerstitial damage or changes in urinary protein excretion (Table  3) . Changes in the logarithmic urinary angiotensinogen:creatinine ratio significantly correlated with scores for glomerulosclerosis (rϭ0.38; Pϭ0.014) or tubulointerstitial damage (ϭ0.36; Pϭ0.021), changes in urinary excretion of protein (rϭ0.63; PϽ0.0001), and SSI (rϭ0.37; Pϭ0.017). Multiple regression analysis of these 3 or 4 explanatory variables revealed that changes in logarithmic urinary angiotensinogen: creatinine ratio correlated with changes in urinary protein excretion rates and SSI but not with the scores for glomerulosclerosis or tubulointerstitial damage (Table 4) . Values are meanϮSD or median (25th and 75th percentiles). 
Urinary Angiotensinogen in Patients With Ménière Disease
None of the outpatients with Ménière disease developed proteinuria or hypertension during the study (Ͻ140/ 90 mm Hg; data not shown). After 4 weeks of consuming a low-salt diet, the urinary excretion rate of sodium significantly decreased from 108Ϯ37 to 67Ϯ21 mEq/d (PϽ0.05), and plasma renin activity significantly increased from 0.97Ϯ0.41 to 1.36Ϯ0.73 ng/mL per hour (PϽ0.05). However, consuming the low-salt diet for 4 weeks did not significantly change either mean blood pressure (data not shown) or the urinary angiotensinogen:creatinine ratio (11.6Ϯ6.7 to 11.1Ϯ4.2 g/g of creatinine).
Discussion
Both preclinical 11, 20, 21 and clinical studies 15, [22] [23] [24] have indicated that urinary angiotensinogen can serve as a specific index of intrarenal RAS status. We showed previously that blood pressure becomes salt sensitive as renal damages progress in patients with normotensive IgA nephropathy. 4 We also found recently that patients with IgA nephropathy have increased urinary angiotensinogen levels, suggesting activation of the intrarenal RAS. 15 We, therefore, investigated the relationship between increased intrarenal RAS activity and the development of salt-sensitive hypertension in patients with IgA nephropathy. The present study is the first to determine that the salt sensitivity of blood pressure significantly correlates with urinary angiotensinogen excretion and renal damage in patients with IgA nephropathy. These data support the hypothesis based on previous preclinical findings 7-12 that salt-induced inappropriate activation of the intrarenal RAS and associated renal damage contribute to the development of salt-sensitive hypertension in patients with CKD. The salt sensitivity of blood pressure is induced by an increase in tubular sodium reabsorption and/or a reduction in the glomerular ultrafiltration coefficient. 1, 25 The present study found that the salt sensitivity of blood pressure significantly correlated with increased levels of urinary angiotensinogen, a marker of intrarenal RAS activity. Therefore, enhanced intrarenal Ang II levels might result in an increase in tubular sodium reabsorption and worsen the salt sensitivity of blood pressure. This notion is supported by recent clinical data showing that an Ang II receptor blocker can enhance natri- uresis in patients with CKD. 26 In agreement with previous clinical findings in patients with IgA nephropathy, 15 the present study found that the filtration fraction was not significantly changed by a short-term high-salt diet in patients with IgA nephropathy. However, we cannot explain why the high-salt diet increased urinary angiotensinogen levels but did not significantly alter the filtration fraction. A high-saltinduced decrease in circulating Ang II might partially compensate for the effect of the activated intrarenal RAS in patients with IgA nephropathy who have diminished but relatively maintained renal function. This notion is supported by the clinical findings that a high-salt diet significantly decreases the filtration fraction in normal individuals but increases it in patients with advanced renal disease. 27 One limitation of the present study is that we could not administer a high-salt diet over the long term to patients with IgA nephropathy because of ethical issues. A high-salt diet significantly increased urinary angiotensinogen excretion in patients with IgA nephropathy but not in those with Ménière disease. Studies in vitro have shown that proximal tubular Ang II production is enhanced by conditioned culture medium from mesangial cells activated by IgA. 28 Furthermore, in mice 29 and in patients 30 with IgA nephropathy, the augmentation of intrarenal angiotensinogen expression is associated with increases in reactive oxygen species. Therefore, we speculate that increases in reactive oxygen species play an important role in mediating the intrarenal augmentation of angiotensinogen as IgA nephropathy progresses, whereas these changes do not occur in patients with Ménière disease who have normal renal function. However, the present study did not investigate reactive oxygen species in the kidney. Further clinical studies are needed to investigate the role of reactive oxygen species in the regulation of intrarenal angiotensinogen and Ang II in patients with IgA nephropathy.
We 31 and others 24 have recently found significantly increased urinary angiotensinogen excretion in patients with CKD. Intrarenal and urinary angiotensinogen levels are also increased in salt-sensitive hypertensive Dahl rats, which are models of human salt-sensitive hypertension. 11, 32 Angiotensinogen is the only known substrate for renin, which is the rate-limiting enzyme of the RAS. Because the level of angiotensinogen is close to the Michaelis-Menten constant for renin, levels not only of renin, but also of angiotensinogen, can dictate the activity of the RAS, and upregulated angiotensinogen levels might lead to increased Ang II formation and consequent sodium reabsorption. 33, 34 This concept is very important for the development of salt-sensitive hypertension in which plasma renin activities are significantly decreased by a high-salt intake. 7 Oxidative stress might participate in intrarenal/urinary enhanced angiotensinogen levels induced by a high-salt intake, because superoxide dismutase mimetics offset such augmentation in Dahl saltsensitive rats. 12 Ohashi et al 35 also showed recently that augmented intrarenal angiotensinogen levels are associated with increased oxidative stress in the kidneys of mice with IgA nephropathy. Furthermore, a recent study in vitro has generated firm evidence that oxidative stress induces Ang II generation via a conformational change of angiotensinogen. 36 However, separate interventional studies are required to address this issue in a clinical setting.
We showed recently that baseline urinary angiotensinogen levels are not correlated with proteinuria in patients with IgA nephropathy and minor glomerular abnormalities. 15 We also showed previously that baseline levels of urinary angiotensinogen and albumin or protein are not always significantly related in hypertensive patients. 23 A high-salt diet increased proteinuria and urinary angiotensinogen levels among patients with IgA nephropathy in the present study. Changes in the excretion rates of urinary protein in these patients positively correlated with changes in urinary angiotensinogen: creatinine ratio. However, SSI positively correlated only with changes in urinary angiotensinogen excretion rate. These data support the concept based on clinical 15, 22, 23, 37 and preclinical 11, 20, 21 evidence indicating that urinary angiotensinogen excretion is not a simple consequence of proteinuria.
Perspectives
The present retrospective exploratory study supports the hypothesis that salt-induced inappropriate augmentation of intrarenal RAS activity and associated renal damage play important roles in the development of salt-sensitive blood pressure in patients with IgA nephropathy. We showed previously that normotensive patients with IgA nephropathy develop salt-sensitive blood pressure, 15 which, together with the present findings, indicates that increases in urinary angiotensinogen levels can predict the progression of saltdependent hypertension. We have already started prospective clinical studies to determine whether increases in urinary angiotensinogen levels can predict the later progression of renal damage and hypertension in patients with metabolic syndrome and type 2 diabetes mellitus who have normal kidney function. 
